Cafepharma Today

January 2 2025 - 10 clinical trials to watch in the first half of 2025
10 clinical trials to watch in the first half of 2025
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
Trump tariffs and drug prices
Neumora laid low by depression trial failure
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Merck licenses prospective bone-building drug from Japan Tobacco for undisclosed amount
Yahoo/AP
Thursday, September 25, 2008 - 10:20am
tags:
OsirisTherapeutics — Cautious Optimism for Stem Cell Company
Cafepharma Detailpiece
Thursday, September 25, 2008 - 10:18am
tags:
Nuvelo, Arca to merge into late-stage cardiovascular biotech
Bizjournals.com
Thursday, September 25, 2008 - 9:45am
tags:
Medicis' Ugly Accounting
Forbes
Thursday, September 25, 2008 - 9:44am
tags:
Novo Nordisk reports positive results for diabetes drug
Marketwatch
Thursday, September 25, 2008 - 9:43am
tags:
Medtronic Will Acquire CryoCath for $380 Million
Bloomberg
Thursday, September 25, 2008 - 9:40am
tags:
Ranbaxy AIDS Drug Won't Be Funded by U.S. After FDA Inspection
Bloomberg
Thursday, September 25, 2008 - 9:39am
tags:
Pharmaceuticals: Pfizer Is a Buy
Seeking Alpha
Thursday, September 25, 2008 - 9:39am
tags:
Sanofi-Aventis to complete Acambis deal
FT.com
Thursday, September 25, 2008 - 9:38am
tags:
Lilly CEO Lechleiter says company plans to grow lean, more diverse to handle industry changes
Yahoo/AP
Thursday, September 25, 2008 - 9:37am
tags:
Big Pharma R&D: Things Are Tough All Over
WSJ Online
Thursday, September 25, 2008 - 9:36am
tags:
Heart Drugs Could Save Billions Over Stents: Study
CNBC
Thursday, September 25, 2008 - 9:03am
tags:
Pfizer Lacking a Catalyst
Yahoo/Zacks.com
Thursday, September 25, 2008 - 9:02am
tags:
Sanofi Gets the Golden Ring
Motley Fool
Thursday, September 25, 2008 - 9:02am
tags:
Biotechnology Drug Costs in U.S. Rise 8.7 Percent, AARP Says
Bloomberg
Thursday, September 25, 2008 - 9:01am
tags:
Glaxo Antidepressants May Damage Sperm, Impair Male Fertility
Bloomberg
Thursday, September 25, 2008 - 8:57am
tags:
Health Winners & Losers: Vertex
The Street.com
Thursday, September 25, 2008 - 8:55am
tags:
Ligand to buy Pharmacopeia for $70 million
Yahoo/AP
Thursday, September 25, 2008 - 8:55am
tags:
Discovery falls after company says new Surfaxin application won't be done until October
Yahoo/AP
Thursday, September 25, 2008 - 8:54am
tags:
Drug stocks mixed, while Sequenom soars
Marketwatch
Wednesday, September 24, 2008 - 11:28am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline
White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels

Latest Jobs

EP Senior Mapping Specialist - Bay Area, CA
San Francisco, California, 94199
Boston Scientific Gruppe
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Sr. Training Manager, Learning & Performance
Yardley, Pennsylvania, 19067
EVERSANA
Area Manager, Immunology West Central Tulsa
Coffeyville, Kansas, 67337
CSL Behring
staff - Registered Nurse (RN) - Clinical Liaison - $80K-90K per year
Houston, Texas, 77246
AccentCare
Pharmaceutical Sales Customer Engagement - Kalamazoo, MI
Michigan, ,
Otsuka
Pharmaceutical Sales Customer Engagement - Wilmington, NC
North Carolina, ,
Otsuka
Pharmaceutical Sales Customer Engagement- Valparaiso, IN
Valparaiso, Indiana,
Otsuka
Area Manager-Specialty Northeast, Albany
Fields, Oregon, 97710
CSL Behring
Pharmaceutical Sales Customer Engagement - Atlanta S, GA
Atlanta, Georgia,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information